아로마뱅크

비상장계속사업자

AROMABANK.CO.LTD

이재홍

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

아로마뱅크

Business Reg. No. 1318196172 · CEO 이재홍

I.Investment Overview

Target아로마뱅크 (1318196172)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명아로마뱅크
영문명AROMABANK.CO.LTD
대표자이재홍
사업자등록번호1318196172
법인등록번호1201110398489
설립일2006.03.15

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW92.52021101.22022112.32023131.52024133.92025
영업이익100M KRW14202112.2202215.8202316.2202414.62025
순이익100M KRW9.920214.720225.120235.720248.32025
Item20252024202320222021
자산총계386.1억원362억원348.1억원341.4억원314.8억원
부채총계280.3억원264.4억원256.2억원254.6억원232.7억원
자본총계105.8억원97.6억원91.9억원86.8억원82.1억원
매출액133.9억원131.5억원112.3억원101.2억원92.5억원
영업이익14.6억원16.2억원15.8억원12.2억원14억원
순이익8.3억원5.7억원5.1억원4.7억원9.9억원

VI.Financial Ratios

FY2025 basis

10.94%

영업이익률

6.17%

순이익률

2.14%

ROA

7.81%

ROE

264.83%

부채비율

27.41%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

아로마뱅크 투심보고서 | Alpha Lenz